Tpeak-Tend interval and Tpeak-T end/QT ratio as markers of ventricular tachycardia inducibility in subjects with Brugada ECG phenotype

Europace

Volumn 12, Issue 2, 2010, Pages 271-274

  Letsas, Konstantinos P ^a   Weber, Reinhold ^a   Astheimer, Klaus ^a   Kalusche, Dietrich ^a   Arentz, Thomas ^a  

^a UNIVERSITY HEART CENTER FREIBURG BAD KROZINGEN   (Germany)

Author keywords

Brugada syndrome; Electrophysiological study; Tpeak T end QT ratio; Tpeak Tend interval; Ventricular arrhythmias

Indexed keywords

AJMALINE; FLECAINIDE; ANTIARRHYTHMIC AGENT; BIOLOGICAL MARKER;

ADULT; ARTICLE; BRUGADA SYNDROME; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE MARKER; ECG ABNORMALITY; ELECTROPHYSIOLOGY; FEMALE; FOLLOW UP; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; MALE; PHENOTYPE; PRIORITY JOURNAL; QT INTERVAL; T WAVE; CHEMICALLY INDUCED DISORDER; ELECTROCARDIOGRAPHY; HEART MUSCLE CONDUCTION SYSTEM; MIDDLE AGED; PATHOPHYSIOLOGY; PREDICTION AND FORECASTING; RETROSPECTIVE STUDY; RISK FACTOR;

ADULT; AJMALINE; ANTI-ARRHYTHMIA AGENTS; BIOLOGICAL MARKERS; BRUGADA SYNDROME; ELECTROCARDIOGRAPHY; FEMALE; FLECAINIDE; HEART CONDUCTION SYSTEM; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; RISK FACTORS; TACHYCARDIA, VENTRICULAR; VENTRICULAR FIBRILLATION;

EID: 76749119089     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eup357     Document Type: Article

References (27)

1. Brugada P, Brugada J. Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. A multicenter report. J Am Coll Cardiol 1992;20:1391-1396
2. Benito B, Brugada R, Brugada J, Brugada P. Brugada syndrome. Prog Cardiovasc Dis 2008;51:1-22.
3. Antzelevitch C, Brugada P, Borggrefe M, Brugada J, Brugada R, Corrado D et al. Brugada syndrome: report of the second consensus conference: endorsed by the Heart Rhythm Society and the European Heart Rhythm Association. Circulation 2005;111:659-670
4. Antzelevitch C, Yan GX, Shimizu W. Transmural dispersion of repolarization and arrhythmogenicity: the Brugada syndrome versus the long QT syndrome. J Electrocardiol 1999;32:S158-65.
5. Castro Hevia J, Antzelevitch C, Tornés Bárzaga F, Dorantes Sánchez M, Dorticó s Balea F, Zayas Molina R et al. Tpeak-Tend and Tpeak-Tend dispersion as risk factors for ventricular tachycardia/ventricular fibrillation in patients with the Brugada syndrome. J Am Coll Cardiol 2006;47:1828-1834
6. Antzelevitch C, Sicouri S, Di Diego JM, Burashnikov A, Viskin S, Shimizu W et al. Does Tpeak-Tend provide an index of transmural dispersion of repolarization? Heart Rhythm 2007;4:1114-1116
7. Yan GX, Antzelevitch C. Cellular basis for the normal T wave and the electrocardiographic manifestations of the long QT syndrome. Circulation 1998; 98:1928-1936 (Pubitemid 28509291)
8. Antzelevitch C, Shimizu W, Yan GX, Sicouri S, Weissenburger J, Nesterenko VV et al. The M cell: its contribution to the ECG and to normal and abnormal electrical function of the heart. J Cardiovasc Electrophysiol 1999;10: 1124-1152
9. Opthof T, Coronel R, Wilms-Schopman FJ, Plotnikov AN, Shlapakova IN, Danilo P Jr et al. Dispersion of repolarization in canine ventricle and the electrocardiographic T wave: Tp-e interval does not reflect transmural dispersion. Heart Rhythm 2007;4:341-348
10. Kors JA, Ritsema van Eck HJ, van Herpen G. The meaning of the Tp-Te interval and its diagnostic value. J Electrocardiol 2008;41:575-580
11. Lubinski A, Lewicka-Nowak E, Kempa M, Baczynska AM, Romanowska I, Swiatecka G. New insight into repolarization abnormalities in patients with congenital long QT syndrome: the increased transmural dispersion of repolarization. Pacing Clin Electrophysiol 1998;21:172-175
12. Shimizu W, Noda T, Takaki H, Kurita T, Nagaya N, Satomi K et al. Epinephrine unmasks latent mutation carriers with LQT1 form of congenital long-QT syndrome. J Am Coll Cardiol 2003;41:633-642
13. Shimizu W, Tanabe Y, Aiba T, Inagaki M, Kurita T, Suyama K et al. Differential effects of beta-blockade on dispersion of repolarization in the absence and presence of sympathetic stimulation between the LQT1 and LQT2 forms of congenital long QT syndrome. J Am Coll Cardiol 2002;39:1984-1991 (Pubitemid 34628279)
14. Takenaka K, Ai T, ShimizuW, Kobori A, Ninomiya T, Otani H et al. Exercise stress test amplifies genotype-phenotype correlation in the LQT1 and LQT2 forms of the long-QT syndrome. Circulation 2003;107:838-844
15. Topilski I, Rogowski O, Rosso R, Justo D, Copperman Y, Glikson M et al. The morphology of the QT interval predicts torsade de pointes during acquired bradyarrhythmias. J Am Coll Cardiol 2007;49:320-328
16. Watanabe N, Kobayashi Y, Tanno K, Miyoshi F, Asano T, Kawamura M et al. Transmural dispersion of repolarization and ventricular tachyarrhythmias. J Electrocardiol 2004;37:191-200.
17. Sangawa M, Morita H, Nakatsu T, Nishii N, Miura D, Miura A et al. Abnormal transmural repolarization process in patients with Brugada syndrome. Heart Rhythm 2009;6:1163-1169
18. Wang JF, Shan QJ, Yang B, Chen ML, Zou JG, Chen C et al. Tpeak-Tend interval and risk of cardiac events in patients with Brugada syndrome. Zhonghua Xin Xue Guan Bing Za Zhi 2007;35:629-632
19. Gupta P, Patel C, Patel H, Narayanaswamy S, Malhotra B, Green JT et al. T(p-e)/ QT ratio as an index of arrhythmogenesis. J Electrocardiol 2008;41:567-574
20. Yamaguchi M, Shimizu M, Ino H, Terai H, Uchiyama K, Oe K et al. T wave peak-to-end interval and QT dispersion in acquired long QT syndrome: a new index for arrhythmogenicity. Clin Sci (Lond) 2003;105:671-676
21. Shimizu M, Ino H, Okeie K, Yamaguchi M, Nagata M, Hayashi K et al. T-peak to T-end interval may be a better predictor of high-risk patients with hypertrophic cardiomyopathy associated with a cardiac troponin I mutation than QT dispersion. Clin Cardiol 2002;25:335-339
22. Paul M, Gerss J, Schulze-Bahr E, Wichter T, Vahlhaus C, Wilde AAM et al. Role of programmed ventricular stimulation in patients with Brugada syndrome: a meta-analysis of worldwide published data. Eur Heart J 2007;28:2126-2133
23. Veltmann C, Schimpf R, Echternach C, Eckardt L, Kuschyk J, Streitner F et al. A prospective study on spontaneous fluctuations between diagnostic and nondiagnostic ECGs in Brugada syndrome: implications for correct phenotyping and risk stratification. Eur Heart J 2006;27:2544-2552
24. Ohkubo K, Watanabe I, Takagi Y, Okumura Y, Ashino S, Kofune M et al. Electrocardiographic and electrophysiologic characteristics in patients with Brugada type electrocardiogram and inducible ventricular fibrillation: single center experience. Circ J 2007;71:1437-1441
25. Yokokawa M, Noda T, Okamura H, Satomi K, Suyama K, Kurita T et al. Comparison of long-term follow-up of electrocardiographic features in Brugada syndrome between the SCN5A-positive probands and the SCN5A-negative probands. Am J Cardiol 2007;100:649-655
26. Catalano O, Antonaci S, Moro G, Mussida M, Frascaroli M, Baldi M et al. Magnetic resonance investigations in Brugada syndrome reveal unexpectedly high rate of structural abnormalities. Eur Heart J 2009;30:2241-2248
27. Gehi AK, Duong TD, Metz LD, Gomes JA, Mehta D. Risk stratification of individuals with the Brugada electrocardiogram: a meta-analysis. J Cardiovasc Electrophysiol 2006;17:577-583